Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

All About Value – Brexit Aside, UK Industry Sees Good Things Ahead For Healthtech Adoption

The ethos of rewarding value and new channels to promote medtech innovation are gaining ground in the UK

Executive Summary

ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.

You may also be interested in...



Hoping For A New Dawn In UK’s Value-Based Procurement

The UK’s MedTech Directorate is undergoing a partial relaunch, with a new director set to take the reins and a new strategy being finalized. The medtech industry hopes the renewed impetus will put long-overdue attention to value-based procurement for medtech goods.

COVID-Delayed UK Medtech Mandate Previews First Products For NHS Adoption

The Medtech Mandate, a scheme that seeks to better match NICE guidance with adoption and use of medtech innovations in the UK, is preparing for launch in April.

NHSX Brings A New Digital Dimension In UK

The UK continues to build its digital health care infrastructure, as seen in the recent funding pledge for a new AI Lab. Andrew Davies is the newly appointed digital health lead at the UK’s ABHI medtech industry association. He says stakeholders first need to understand the scope of digital health care, and then adopt a networked approach, with medtech playing a full part in that evolution.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel